Michael F MacLean

CIK 1383731 · Chief Financial Officer · last filed 2026-04-03

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$2.90M

Companies

6

Total Filings

54

Lifetime Open-Market Net

-$16.65M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CAMP Director $4.19 $0 1 2026-04-03
Avidity Biosciences, Inc. (RNAM) Delisted Chief Financial Officer 0 $0 1 2026-02-27
RNA Chief Financial Officer 62,025 $12.37 $767.2K -$15.13M 18 2026-01-23
Verve Therapeutics, Inc. (VERV) Delisted Director $11.13 $0 7 2025-07-28
AKCEA THERAPEUTICS, INC. (AKCA) Delisted Chief Financial Officer 48,000 $0 6 2020-01-16
BIIB SVP, Chief Accounting Officer 10,681 $200.05 $2.14M -$1.52M 21 2010-10-04

Recent Filings · Page 6 of 6

54 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2008-02-14 BIIB Mixed +7,140 -$67.8K EDGAR
2007-11-02 BIIB Mixed +682 -$23.2K EDGAR
2007-10-02 BIIB Grant (A) +9,000 $0 EDGAR
2007-02-14 BIIB Grant (A) +10,000 $0 EDGAR
Showing 5154 of 54
Page 6 of 6
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.